A01K 2267/03
Animal model
Official title: Animal model, e.g. for test or diseases
A01K2267/03 (Animal model) appears on 3,543 US grants and 6,660 published applications in this corpus.
Search patents in A01K- Granted patents
- 3,543
- Published applications
- 6,660
- Assignees
- 2,276
- Inventors
- 12,372
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 11 | 0 |
| 1996 | 45 | 0 |
| 1997 | 56 | 0 |
| 1998 | 91 | 0 |
| 1999 | 102 | 0 |
| 2000 | 99 | 0 |
| 2001 | 108 | 24 |
| 2002 | 81 | 235 |
| 2003 | 103 | 302 |
| 2004 | 81 | 245 |
| 2005 | 73 | 287 |
| 2006 | 103 | 318 |
| 2007 | 111 | 284 |
| 2008 | 92 | 284 |
| 2009 | 107 | 282 |
| 2010 | 144 | 298 |
| 2011 | 121 | 270 |
| 2012 | 122 | 205 |
| 2013 | 132 | 186 |
| 2014 | 113 | 164 |
| 2015 | 136 | 214 |
| 2016 | 113 | 219 |
| 2017 | 132 | 196 |
| 2018 | 112 | 230 |
| 2019 | 123 | 295 |
| 2020 | 137 | 343 |
| 2021 | 137 | 339 |
| 2022 | 131 | 372 |
| 2023 | 143 | 344 |
| 2024 | 166 | 304 |
| 2025 | 181 | 267 |
| 2026 | 124 | 153 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A01K 2267/035Animal model for multifactorial diseasesIndexing code1,277
- A01K 2267/0306Animal model for genetic diseasesIndexing code896
- A01K 2267/0331Animal model for proliferative diseasesIndexing code639
- A01K 2267/0393Animal model comprising a reporter system for screening testsIndexing code453
- A01K 2267/0337Animal models for infectious diseasesIndexing code245
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Non-canonical SWI/SNF complex and uses thereof8 Sep 2026US 12,729,225 B2Dana-Farber Cancer Institute, Inc.
- Rat models for CMT2A that develop a progressive neuropathy1 Sep 2026US 12,721,327 B2Charcot-Marie-Tooth Association
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Mouse model with humanized telomere1 Oct 2026US 2026/0293864 A1Washington State Univesity
- Animal models, screening methods, and treatment methods for intraocular diseases or disorders24 Sep 2026US 2026/0283123 A1Smilebiotek Zhuhai Limited
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,541US 5,661,016 AGenPharm International, Inc. · 1997
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- Generation of xenogeneic antibodies639US 6,114,598 AAbgenix, Inc. · 2000